Log In
Print this Print this

IMP321 (formerly ImmuFact IMP321)

  Manage Alerts
Collapse Summary General Information
Company Prima BioMed Ltd.
DescriptionNatural human T cell immunostimulatory factor derived from soluble lymphocyte activation gene 3 (LAG3)
Molecular Target Major histocompatibility complex class II (MHCII) ; Lymphocyte-activation gene 3 (LAG3) (CD223)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today